Myanmar

Myanmar

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.39 (1.99 - 2.71) 2019 Modelled IHME
2.45 (2.09 - 2.76) 2018 Modelled IHME
2.5 (2.14 - 2.85) 2017 Modelled IHME
2.53 (2.17 - 2.86) 2016 Modelled IHME
2.56 (2.18 - 2.92) 2015 Modelled IHME
2.6 (2.22 - 2.98) 2014 Modelled IHME
2.66 (2.27 - 3.06) 2013 Modelled IHME
2.73 (2.33 - 3.14) 2012 Modelled IHME
2.79 (2.36 - 3.24) 2011 Modelled IHME
2.84 (2.39 - 3.32) 2010 Modelled IHME
2.89 (2.43 - 3.37) 2009 Modelled IHME
2.93 (2.44 - 3.39) 2008 Modelled IHME
2.98 (2.46 - 3.44) 2007 Modelled IHME
3.01 (2.49 - 3.49) 2006 Modelled IHME
3.05 (2.52 - 3.54) 2005 Modelled IHME
3.08 (2.56 - 3.58) 2004 Modelled IHME
3.12 (2.59 - 3.62) 2003 Modelled IHME
3.15 (2.63 - 3.63) 2002 Modelled IHME
3.18 (2.65 - 3.65) 2001 Modelled IHME
3.21 (2.66 - 3.71) 2000 Modelled IHME
3.24 (2.71 - 3.74) 1999 Modelled IHME
3.28 (2.76 - 3.78) 1998 Modelled IHME
3.31 (2.80 - 3.83) 1997 Modelled IHME
3.33 (2.82 - 3.86) 1996 Modelled IHME
3.34 (2.82 - 3.88) 1995 Modelled IHME
3.34 (2.82 - 3.87) 1994 Modelled IHME
3.32 (2.79 - 3.84) 1993 Modelled IHME
3.28 (2.75 - 3.81) 1992 Modelled IHME
3.24 (2.69 - 3.76) 1991 Modelled IHME
3.19 (2.63 - 3.71) 1990 Modelled IHME
8.7 2013 Survey/reported Zaw S et al, 2013
4.18 (0.28 - 41.28) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.61 (0.46 - 0.82) 2019 Modelled IHME
0.64 (0.48 - 0.88) 2018 Modelled IHME
0.68 (0.50 - 0.92) 2017 Modelled IHME
0.73 (0.56 - 0.97) 2016 Modelled IHME
0.76 (0.58 - 0.99) 2015 Modelled IHME
0.76 (0.57 - 0.98) 2014 Modelled IHME
0.74 (0.56 - 0.97) 2013 Modelled IHME
0.73 (0.54 - 0.96) 2012 Modelled IHME
0.72 (0.53 - 0.96) 2011 Modelled IHME
0.71 (0.52 - 0.96) 2010 Modelled IHME
0.72 (0.53 - 0.96) 2009 Modelled IHME
0.75 (0.55 - 1) 2008 Modelled IHME
0.79 (0.58 - 1.04) 2007 Modelled IHME
0.84 (0.62 - 1.11) 2006 Modelled IHME
0.9 (0.66 - 1.19) 2005 Modelled IHME
1.07 (0.79 - 1.40) 2004 Modelled IHME
1.38 (1.03 - 1.80) 2003 Modelled IHME
1.73 (1.29 - 2.28) 2002 Modelled IHME
2.03 (1.53 - 2.68) 2001 Modelled IHME
2.18 (1.63 - 2.91) 2000 Modelled IHME
2.23 (1.67 - 2.95) 1999 Modelled IHME
2.27 (1.67 - 2.97) 1998 Modelled IHME
2.29 (1.67 - 3.01) 1997 Modelled IHME
2.31 (1.70 - 3.04) 1996 Modelled IHME
2.32 (1.71 - 3.07) 1995 Modelled IHME
2.31 (1.70 - 3.02) 1994 Modelled IHME
2.29 (1.69 - 2.98) 1993 Modelled IHME
2.26 (1.66 - 2.93) 1992 Modelled IHME
2.22 (1.64 - 2.88) 1991 Modelled IHME
2.17 (1.58 - 2.83) 1990 Modelled IHME
2.03 (0.13 - 25.84) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
12.2 (8.57 - 17.20) 2019 Modelled IHME
12.3 (8.72 - 17.20) 2018 Modelled IHME
12 (8.62 - 16.50) 2017 Modelled IHME
12 (8.64 - 16.30) 2016 Modelled IHME
12.5 (9 - 16.70) 2015 Modelled IHME
13.1 (9.64 - 17.20) 2014 Modelled IHME
13.9 (10.50 - 17.90) 2013 Modelled IHME
14.6 (11.10 - 18.80) 2012 Modelled IHME
15.4 (11.80 - 19.70) 2011 Modelled IHME
15.6 (12.10 - 19.90) 2010 Modelled IHME
15.7 (12.30 - 20.10) 2009 Modelled IHME
15.8 (12.30 - 20) 2008 Modelled IHME
15.9 (12.30 - 20.20) 2007 Modelled IHME
16 (12.10 - 20.60) 2006 Modelled IHME
16 (11.90 - 20.60) 2005 Modelled IHME
16 (11.90 - 20.70) 2004 Modelled IHME
15.9 (11.60 - 20.50) 2003 Modelled IHME
15.8 (11.60 - 20.70) 2002 Modelled IHME
15.7 (11.60 - 20.40) 2001 Modelled IHME
15.4 (11.30 - 20.20) 2000 Modelled IHME
15.2 (11 - 20.10) 1999 Modelled IHME
15.2 (11 - 20.30) 1998 Modelled IHME
15.2 (11 - 20.30) 1997 Modelled IHME
15.1 (10.90 - 20.60) 1996 Modelled IHME
15.1 (10.90 - 20.60) 1995 Modelled IHME
15.1 (10.80 - 20.80) 1994 Modelled IHME
15.1 (10.80 - 20.40) 1993 Modelled IHME
15 (10.60 - 20.70) 1992 Modelled IHME
15 (10.70 - 20.70) 1991 Modelled IHME
14.9 (10.60 - 20.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
6,644 (4,685 - 9,380) 2019 Modelled IHME
6,643 (4,728 - 9,313) 2018 Modelled IHME
6,473 (4,639 - 8,894) 2017 Modelled IHME
6,386 (4,610 - 8,717) 2016 Modelled IHME
6,591 (4,760 - 8,848) 2015 Modelled IHME
6,878 (5,054 - 9,005) 2014 Modelled IHME
7,232 (5,443 - 9,314) 2013 Modelled IHME
7,550 (5,741 - 9,700) 2012 Modelled IHME
7,872 (6,049 - 10,093) 2011 Modelled IHME
7,906 (6,119 - 10,096) 2010 Modelled IHME
7,905 (6,166 - 10,074) 2009 Modelled IHME
7,865 (6,122 - 9,992) 2008 Modelled IHME
7,892 (6,073 - 10,012) 2007 Modelled IHME
7,873 (5,928 - 10,084) 2006 Modelled IHME
7,781 (5,794 - 10,024) 2005 Modelled IHME
7,721 (5,755 - 9,965) 2004 Modelled IHME
7,572 (5,563 - 9,797) 2003 Modelled IHME
7,494 (5,510 - 9,775) 2002 Modelled IHME
7,357 (5,424 - 9,551) 2001 Modelled IHME
7,159 (5,253 - 9,379) 2000 Modelled IHME
6,973 (5,037 - 9,256) 1999 Modelled IHME
6,901 (4,988 - 9,245) 1998 Modelled IHME
6,817 (4,933 - 9,154) 1997 Modelled IHME
6,739 (4,840 - 9,157) 1996 Modelled IHME
6,659 (4,784 - 9,065) 1995 Modelled IHME
6,567 (4,697 - 9,016) 1994 Modelled IHME
6,473 (4,629 - 8,763) 1993 Modelled IHME
6,367 (4,504 - 8,762) 1992 Modelled IHME
6,256 (4,482 - 8,643) 1991 Modelled IHME
6,119 (4,365 - 8,381) 1990 Modelled IHME
14,284 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
33 (25 - 43) 2019 Modelled IHME
33 (25 - 43) 2018 Modelled IHME
33 (25 - 43) 2017 Modelled IHME
34 (25 - 44) 2016 Modelled IHME
34 (26 - 44) 2015 Modelled IHME
35 (27 - 45) 2014 Modelled IHME
35 (27 - 45) 2013 Modelled IHME
36 (27 - 46) 2012 Modelled IHME
36 (28 - 46) 2011 Modelled IHME
36 (28 - 46) 2010 Modelled IHME
36 (28 - 46) 2009 Modelled IHME
36 (28 - 46) 2008 Modelled IHME
36 (28 - 46) 2007 Modelled IHME
36 (28 - 46) 2006 Modelled IHME
36 (28 - 46) 2005 Modelled IHME
36 (28 - 47) 2004 Modelled IHME
36 (28 - 47) 2003 Modelled IHME
36 (28 - 47) 2002 Modelled IHME
37 (28 - 47) 2001 Modelled IHME
37 (28 - 47) 2000 Modelled IHME
37 (28 - 47) 1999 Modelled IHME
37 (28 - 47) 1998 Modelled IHME
37 (28 - 47) 1997 Modelled IHME
37 (28 - 47) 1996 Modelled IHME
37 (28 - 47) 1995 Modelled IHME
37 (28 - 47) 1994 Modelled IHME
37 (28 - 47) 1993 Modelled IHME
37 (28 - 47) 1992 Modelled IHME
37 (28 - 47) 1991 Modelled IHME
37 (28 - 48) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
7 2018 Survey/reported WHO/UNICEF
1 2017 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
89 2017 Survey/reported WHO/UNICEF
90 2016 Survey/reported WHO/UNICEF
89 2015 Survey/reported WHO/UNICEF
88 2014 Survey/reported WHO/UNICEF
75 2013 Survey/reported WHO/UNICEF
58 2012 Survey/reported WHO/UNICEF
40 2011 Survey/reported WHO/UNICEF
92 2010 Survey/reported WHO/UNICEF
91 2009 Survey/reported WHO/UNICEF
85 2008 Survey/reported WHO/UNICEF
85 2007 Survey/reported WHO/UNICEF
75 2006 Survey/reported WHO/UNICEF
62 2005 Survey/reported WHO/UNICEF
39 2004 Survey/reported WHO/UNICEF
8 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
80 (59 - 120) 2015 Survey/reported HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2016
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
No
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.82 (1.48 - 2.22) 2019 Modelled IHME
1.82 (1.49 - 2.23) 2018 Modelled IHME
1.83 (1.48 - 2.25) 2017 Modelled IHME
1.83 (1.50 - 2.24) 2016 Modelled IHME
1.83 (1.49 - 2.25) 2015 Modelled IHME
1.84 (1.49 - 2.25) 2014 Modelled IHME
1.84 (1.49 - 2.25) 2013 Modelled IHME
1.85 (1.49 - 2.29) 2012 Modelled IHME
1.85 (1.49 - 2.29) 2011 Modelled IHME
1.86 (1.48 - 2.30) 2010 Modelled IHME
1.87 (1.50 - 2.32) 2009 Modelled IHME
1.88 (1.51 - 2.31) 2008 Modelled IHME
1.89 (1.52 - 2.34) 2007 Modelled IHME
1.9 (1.53 - 2.36) 2006 Modelled IHME
1.91 (1.55 - 2.37) 2005 Modelled IHME
1.93 (1.57 - 2.39) 2004 Modelled IHME
1.95 (1.58 - 2.41) 2003 Modelled IHME
1.97 (1.60 - 2.43) 2002 Modelled IHME
1.99 (1.62 - 2.45) 2001 Modelled IHME
2.01 (1.63 - 2.46) 2000 Modelled IHME
2.02 (1.63 - 2.48) 1999 Modelled IHME
2.03 (1.64 - 2.50) 1998 Modelled IHME
2.04 (1.64 - 2.52) 1997 Modelled IHME
2.04 (1.65 - 2.52) 1996 Modelled IHME
2.05 (1.64 - 2.53) 1995 Modelled IHME
2.05 (1.65 - 2.53) 1994 Modelled IHME
2.05 (1.64 - 2.53) 1993 Modelled IHME
2.06 (1.64 - 2.54) 1992 Modelled IHME
2.06 (1.64 - 2.53) 1991 Modelled IHME
2.06 (1.64 - 2.54) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.95 (0.34 - 2.03) 2010 Survey/reported Myo-Khin et al, 2010
1.7 (1 - 2.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
29.5 (26.90 - 32.20) 2010 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
12.5 (8.81 - 17.10) 2019 Modelled IHME
12.6 (8.94 - 17.30) 2018 Modelled IHME
12.4 (8.81 - 16.90) 2017 Modelled IHME
11.9 (8.54 - 16.20) 2016 Modelled IHME
11.8 (8.47 - 16) 2015 Modelled IHME
11.5 (8.31 - 15.50) 2014 Modelled IHME
11.2 (8.03 - 15) 2013 Modelled IHME
10.8 (7.82 - 14.70) 2012 Modelled IHME
10.6 (7.61 - 14.40) 2011 Modelled IHME
10.5 (7.58 - 14.30) 2010 Modelled IHME
10.5 (7.65 - 14.50) 2009 Modelled IHME
10.6 (7.67 - 14.70) 2008 Modelled IHME
10.8 (7.78 - 14.90) 2007 Modelled IHME
10.9 (7.85 - 15.10) 2006 Modelled IHME
10.9 (7.79 - 15.10) 2005 Modelled IHME
10.8 (7.75 - 15) 2004 Modelled IHME
10.7 (7.62 - 14.80) 2003 Modelled IHME
10.6 (7.59 - 14.60) 2002 Modelled IHME
10.5 (7.44 - 14.40) 2001 Modelled IHME
10.3 (7.23 - 14.20) 2000 Modelled IHME
10.1 (7.15 - 14.10) 1999 Modelled IHME
10.1 (7.05 - 14.10) 1998 Modelled IHME
10.1 (6.97 - 14) 1997 Modelled IHME
10.1 (6.89 - 14.10) 1996 Modelled IHME
10.1 (6.87 - 14.10) 1995 Modelled IHME
10.1 (6.82 - 14.20) 1994 Modelled IHME
10.1 (6.77 - 14.20) 1993 Modelled IHME
10 (6.83 - 14.10) 1992 Modelled IHME
10 (6.83 - 14) 1991 Modelled IHME
9.97 (6.87 - 14) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
6,829 (4,819 - 9,376) 2019 Modelled IHME
6,849 (4,849 - 9,398) 2018 Modelled IHME
6,660 (4,741 - 9,106) 2017 Modelled IHME
6,370 (4,558 - 8,669) 2016 Modelled IHME
6,233 (4,481 - 8,488) 2015 Modelled IHME
6,054 (4,359 - 8,105) 2014 Modelled IHME
5,802 (4,177 - 7,825) 2013 Modelled IHME
5,548 (4,029 - 7,556) 2012 Modelled IHME
5,418 (3,891 - 7,365) 2011 Modelled IHME
5,300 (3,840 - 7,241) 2010 Modelled IHME
5,297 (3,841 - 7,285) 2009 Modelled IHME
5,287 (3,825 - 7,307) 2008 Modelled IHME
5,326 (3,850 - 7,375) 2007 Modelled IHME
5,332 (3,852 - 7,415) 2006 Modelled IHME
5,278 (3,787 - 7,319) 2005 Modelled IHME
5,227 (3,735 - 7,231) 2004 Modelled IHME
5,107 (3,638 - 7,050) 2003 Modelled IHME
5,026 (3,591 - 6,890) 2002 Modelled IHME
4,910 (3,487 - 6,742) 2001 Modelled IHME
4,761 (3,356 - 6,592) 2000 Modelled IHME
4,632 (3,286 - 6,486) 1999 Modelled IHME
4,585 (3,207 - 6,389) 1998 Modelled IHME
4,532 (3,134 - 6,295) 1997 Modelled IHME
4,485 (3,064 - 6,269) 1996 Modelled IHME
4,435 (3,022 - 6,219) 1995 Modelled IHME
4,377 (2,964 - 6,167) 1994 Modelled IHME
4,319 (2,903 - 6,086) 1993 Modelled IHME
4,252 (2,890 - 5,972) 1992 Modelled IHME
4,182 (2,848 - 5,853) 1991 Modelled IHME
4,096 (2,823 - 5,747) 1990 Modelled IHME
3,792 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
30 (22 - 39) 2019 Modelled IHME
30 (22 - 38) 2018 Modelled IHME
30 (22 - 38) 2017 Modelled IHME
30 (22 - 38) 2016 Modelled IHME
30 (22 - 38) 2015 Modelled IHME
30 (22 - 38) 2014 Modelled IHME
30 (22 - 38) 2013 Modelled IHME
30 (22 - 38) 2012 Modelled IHME
30 (22 - 38) 2011 Modelled IHME
30 (22 - 38) 2010 Modelled IHME
30 (22 - 38) 2009 Modelled IHME
30 (22 - 38) 2008 Modelled IHME
30 (22 - 38) 2007 Modelled IHME
30 (22 - 38) 2006 Modelled IHME
30 (22 - 38) 2005 Modelled IHME
30 (22 - 38) 2004 Modelled IHME
30 (22 - 38) 2003 Modelled IHME
30 (22 - 38) 2002 Modelled IHME
30 (22 - 38) 2001 Modelled IHME
30 (21 - 38) 2000 Modelled IHME
30 (21 - 38) 1999 Modelled IHME
30 (21 - 38) 1998 Modelled IHME
29 (21 - 38) 1997 Modelled IHME
29 (21 - 38) 1996 Modelled IHME
29 (21 - 38) 1995 Modelled IHME
29 (21 - 38) 1994 Modelled IHME
29 (21 - 38) 1993 Modelled IHME
29 (21 - 37) 1992 Modelled IHME
29 (20 - 38) 1991 Modelled IHME
29 (20 - 38) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (59 - 120) 2015 Survey/reported HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2016
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
No
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
2.39 (%)
2019
(1.99 - 2.71(%))
IHME
HCV (RNA/cAg+)
1.82 (%)
2019
(1.48 - 2.22(%))
IHME

Survey/surveillance

HBV (HBsAg+)
8.7 (%)
2013
Zaw S et al, 2013
HCV (anti-HCV)
0.95 (%)
2010
(0.34 - 2.03(%))
Myo-Khin et al, 2010

Hepatitis related deaths (national)

Modelled

HBV
6,644
2019
(4,685 - 9,380)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
6,829
2019
(4,819 - 9,376)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.61 (%)
2019, latest modelled
(0.46 - 0.82(%))
IHME

Prevalence PWID

HCV
29.50 (%)
2010, latest modelled
(26.90 - 32.20(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
7 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
80
2015
(59 - 120)
HIV And AIDS Data Hub for Asia-Pacific, 2014; Myanmar National AIDS Programme, 2015.
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Action plan

View all
health clinic
group photo
healthworker in clinic
Previous Next

Action plans

Resources

Programs